Travere Therapeutics Turns a Rare Disease Approval into Two Quarters of Accelerating Sales
The Food and Drug Administration granted Travere Therapeutics full approval for FILSPARI in focal segmental glomerulosclerosis on April 13, 2026, the ...
Last updated: 2026-08-23 01:23:03 ET
The Food and Drug Administration granted Travere Therapeutics full approval for FILSPARI in focal segmental glomerulosclerosis on April 13, 2026, the ...
When an agentic AI system hands a task from a small model to a larger one — or back down again — it pays a steep tax: the receiving model has to r...
Washington has favored bullets over business in its dealings with slow-growing Ecuador.
As Vice President JD Vance declares economic pressure "the most effective tool that we have," Iran seeks to show deepening trade ties with its neighbo...
If you were worried about killer cyborgs taking over the world anytime soon, you can breathe a sigh of relief for the moment. Artificial intelligence ...
A U.S. Air Force C-17A Globemaster III taking off from Christchurch, New Zealand, returned after receiving a “potentially hazardous” space activit...
Treasury Secretary Scott Bessent is reinventing the government’s role in the world’s most important bond market.
What's old is new again in Molsheim.
Victorian court of appeal also to consider whether triple murder and attempted murder convictions should be quashedErin Patterson argues mushroom murd...
Factory-stock Desert Rated hardware turns the Jeep Gladiator Mojave into a real-world test bed across 1,500 miles of Rebelle Rally stages.
Unlock the AI Macro Analyst to drill down into the data, explore hidden risks, and query the entire market briefing in real-time.
LOG IN / SUBSCRIBE